Breach of Warranty Claim in La. Federal Ozempic Action Dismissed for Good



DOCUMENTS
  • Order


LAKE CHARLES, La. — A Louisiana federal judge has dismissed with prejudice a breach of express warranty claim asserted in a lawsuit accusing Novo Nordisk A/S of failing to warn that its type 2 diabetes drug Ozempic can cause severe gastrointestinal issues.

On Jan. 9, Judge James D. Cain Jr. of the U.S. District Court for the Western District of Louisiana explained that the claim had been dismissed in early December with leave to amend, but the plaintiff never filed an amended complaint.

Ozempic (semaglutide) stimulates insulin production and reducing glucose production in the liver helping to lower blood sugar …






UPCOMING CONFERENCES




HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS



HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024 - Salt Lake City, UT
The Grand America Hotel

MORE DETAILS